Dearborn Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Buy |
5,549
+133
| +2% | +$6.43K | 0.01% | 231 |
|
|
2025
Q1 | $300K | Sell |
5,416
-305
| -5% | -$16.9K | 0.01% | 207 |
|
|
2024
Q4 | $276K | Buy |
5,721
+126
| +2% | +$6.08K | 0.01% | 225 |
|
|
2024
Q3 | $322K | Buy |
5,595
+47
| +0.8% | +$2.71K | 0.01% | 219 |
|
|
2024
Q2 | $269K | Hold |
5,548
| – | – | 0.01% | 227 |
|
|
2024
Q1 | $270K | Buy |
5,548
+285
| +5% | +$13.9K | 0.01% | 226 |
|
|
2023
Q4 | $262K | Sell |
5,263
-1,174
| -18% | -$58.4K | 0.01% | 222 |
|
|
2023
Q3 | $345K | Buy |
6,437
+125
| +2% | +$6.71K | 0.01% | 176 |
|
|
2023
Q2 | $340K | Sell |
6,312
-155
| -2% | -$8.36K | 0.01% | 175 |
|
|
2023
Q1 | $352K | Buy |
6,467
+137
| +2% | +$7.46K | 0.01% | 174 |
|
|
2022
Q4 | $307K | Buy |
6,330
+16
| +0.3% | +$775 | 0.01% | 191 |
|
|
2022
Q3 | $240K | Buy |
6,314
+199
| +3% | +$7.56K | 0.01% | 221 |
|
|
2022
Q2 | $306K | Hold |
6,115
| – | – | 0.01% | 195 |
|
|
2022
Q1 | $314K | Buy |
6,115
+207
| +4% | +$10.6K | 0.01% | 201 |
|
|
2021
Q4 | $296K | Buy |
5,908
+268
| +5% | +$13.4K | 0.01% | 217 |
|
|
2021
Q3 | $272K | Buy |
5,640
+20
| +0.4% | +$965 | 0.01% | 210 |
|
|
2021
Q2 | $296K | Hold |
5,620
| – | – | 0.01% | 207 |
|
|
2021
Q1 | $278K | Hold |
5,620
| – | – | 0.01% | 210 |
|
|
2020
Q4 | $273K | Hold |
5,620
| – | – | 0.01% | 213 |
|
|
2020
Q3 | $282K | Sell |
5,620
-181
| -3% | -$9.08K | 0.01% | 189 |
|
|
2020
Q2 | $296K | Hold |
5,801
| – | – | 0.02% | 176 |
|
|
2020
Q1 | $254K | Hold |
5,801
| – | – | 0.02% | 187 |
|
|
2019
Q4 | $291K | Hold |
5,801
| – | – | 0.01% | 199 |
|
|
2019
Q3 | $269K | Hold |
5,801
| – | – | 0.02% | 188 |
|
|
2019
Q2 | $251K | Buy |
+5,801
| New | +$251K | 0.02% | 180 |
|